Harrow, Inc.
HROW
#5590
Rank
C$2.02 B
Marketcap
C$54.44
Share price
-0.44%
Change (1 day)
18.22%
Change (1 year)

Earnings for Harrow, Inc. (HROW)

Earnings in 2026 (TTM): C$15.98 Million

According to Harrow, Inc.'s latest financial reports the company's current earnings are C$0.26 Billion. In 2025 the company made an earning of C$32.03 Million, an increase over its 2024 earnings that were of C$7.67 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Harrow, Inc. from 2007 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$15.98 M-50.1%
2025 C$32.03 M317.34%
2024 C$7.67 M-329.09%
2023 -C$3.36 Million-224.34%
2022 C$2.69 M3.01%
2021 C$2.61 M149.06%
2020 C$1.05 M434.29%
2019 C$0.19 M-102.68%
2018 -C$7.33 Million-57.11%
2017 -C$17.08 Million-21.93%
2016 -C$21.88 Million5.11%
2015 -C$20.82 Million46.16%
2014 -C$14.24 Million32.68%
2013 -C$10.74 Million42.63%
2012 -C$7.53 Million
2010 -C$3.48 Million-45.76%
2009 -C$6.41 Million21.83%
2008 -C$5.27 Million-491.97%
2007 C$1.34 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-C$0.33 Billion-2,013.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-C$25.5 Million-251.76%๐Ÿ‡บ๐Ÿ‡ธ USA